Different HMGCR-inhibiting statins vary in their association with increased survival in patients with COVID-19.
Megan M SperryTomiko T OskotskyIvana MariÄShruti KaushalTakako TakedaViktor HorvathRani K PowersMelissa RodasBrooke FurlongMercy SoongPranav PrabhalaGirija GoyalKenneth E CarlsonRonald J WongIdit KostiBrian L LeJames P LogueHolly HammondMatthew B FriemannDavid K StevensonDonald E IngberMarina SirotaRichard NovakPublished in: medRxiv : the preprint server for health sciences (2022)
DARPA, Wyss Institute, Hess Research Fund, UCSF Program for Breakthrough Biomedical Research, and NIH.